vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
38.30
+2.09 (5.77%)
Mar 25, 2026, 4:00 PM EDT - Market closed
vTv Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
26
Market Cap
150.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 1.02M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 2.02M | -1.99M | -49.61% |
| Dec 31, 2021 | 4.01M | -2.41M | -37.56% |
| Dec 31, 2020 | 6.41M | 3.65M | 132.05% |
| Dec 31, 2019 | 2.76M | -9.67M | -77.77% |
| Dec 31, 2018 | 12.43M | 12.14M | 4,172.85% |
| Dec 31, 2017 | 291.00K | -343.00K | -54.10% |
| Dec 31, 2016 | 634.00K | 115.00K | 22.16% |
| Dec 31, 2015 | 519.00K | -1.03M | -66.49% |
| Dec 31, 2014 | 1.55M | 573.00K | 58.71% |
| Dec 31, 2013 | 976.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVTVT News
- 9 days ago - vTv Therapeutics to Participate in the 38th Annual ROTH Conference - GlobeNewsWire
- 15 days ago - vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 26 days ago - VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst - Seeking Alpha
- 5 weeks ago - vTv Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewsWire
- 3 months ago - vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - GlobeNewsWire
- 4 months ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire